1. Considering the oral bioavailability of protein kinase inhibitors: Essential in assessing the extent of drug–drug interaction and improving clinical practice;Le Louedec,2023
2. Drug-drug interactions with tyrosine-kinase inhibitors: a clinical perspective;van Leeuwen,2014
3. Metabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: Current understanding, challenges and recommendations;Teo,2015
4. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung,2021
5. Review of cyclin-dependent kinase 4/6 inhibitors for the treatment of hormone receptor–positive advanced breast cancer;Hecht,2019